




Searching News Database: Gleevec
HSMN NewsFeed - 28 Oct 2021
BioTheryX Announces Appointment of Philippe Drouet as Chief Executive Officer
BioTheryX Announces Appointment of Philippe Drouet as Chief Executive Officer
HSMN NewsFeed - 30 Nov 2017
Merrimack Announces Appointment of George Demetri, M.D., to Board of Directors
Merrimack Announces Appointment of George Demetri, M.D., to Board of Directors
HSMN NewsFeed - 27 Sep 2016
Neon Therapeutics Appoints Oncology Veteran Hugh O’Dowd to Chief Executive Officer
Neon Therapeutics Appoints Oncology Veteran Hugh O’Dowd to Chief Executive Officer
HSMN NewsFeed - 28 Apr 2011
Arno Therapeutics Announces the Appointment of Mr. Glenn Mattes as President and Chief Executive Officer
Arno Therapeutics Announces the Appointment of Mr. Glenn Mattes as President and Chief Executive Officer
HSMN NewsFeed - 4 Jun 2010
New Data at ASCO Show Novartis Drug Tasigna(R) Surpasses Gleevec(R) for Newly Diagnosed CML Patients
New Data at ASCO Show Novartis Drug Tasigna(R) Surpasses Gleevec(R) for Newly Diagnosed CML Patients
HSMN NewsFeed - 20 Jan 2010
Medco to Advance Cancer Care with Personalized and Specialized Treatment for Oncology Patients
Medco to Advance Cancer Care with Personalized and Specialized Treatment for Oncology Patients
HSMN NewsFeed - 18 Nov 2009
Asuragen Signs Development and Worldwide Distribution Agreement with Life Technologies
Asuragen Signs Development and Worldwide Distribution Agreement with Life Technologies
HSMN NewsFeed - 8 Nov 2007
FDA Approves New SPRYCEL(R) (Dasatinib) Product Labeling for Patients with Chronic-Phase CML
FDA Approves New SPRYCEL(R) (Dasatinib) Product Labeling for Patients with Chronic-Phase CML
HSMN NewsFeed - 4 Jul 2007
Researchers Identify Genetic Mutation That May Alter Patients' Response to Cancer Therapeutics
Researchers Identify Genetic Mutation That May Alter Patients' Response to Cancer Therapeutics
HSMN NewsFeed - 20 Feb 2007
Tapestry Pharmaceuticals Appoints Sandra L. Silberman, M.D., Ph.D. As Chief Medical Officer
Tapestry Pharmaceuticals Appoints Sandra L. Silberman, M.D., Ph.D. As Chief Medical Officer
HSMN NewsFeed - 10 Jan 2007
Panacea Pharmaceuticals Appoints Pamela Harris, MD, Vice President Medical and Clinical Affairs
Panacea Pharmaceuticals Appoints Pamela Harris, MD, Vice President Medical and Clinical Affairs
HSMN NewsFeed - 13 Dec 2006
Ambit Biosciences Announces Establishment of Clinical Oncology Advisory Board
Ambit Biosciences Announces Establishment of Clinical Oncology Advisory Board
HSMN NewsFeed - 14 Nov 2006
ChemGenex Announces Granting of Fast Track Status for Ceflatonin(R) by FDA
ChemGenex Announces Granting of Fast Track Status for Ceflatonin(R) by FDA
HSMN NewsFeed - 1 Nov 2006
Avalon Pharmaceuticals Names Todd R. Golub, M.D. as Chairman and Member of Its Scientific Advisory Board
Avalon Pharmaceuticals Names Todd R. Golub, M.D. as Chairman and Member of Its Scientific Advisory Board
HSMN NewsFeed - 19 Oct 2006
Gleevec(R) Approved in the US for Five Rare Life-Threatening Disorders With Limited Treatment Options
Gleevec(R) Approved in the US for Five Rare Life-Threatening Disorders With Limited Treatment Options
HSMN NewsFeed - 21 Jun 2006
Tranzyme Pharma Appoints Industry Veteran as Senior Vice President of Research and Preclinical Development
Tranzyme Pharma Appoints Industry Veteran as Senior Vice President of Research and Preclinical Development
HSMN NewsFeed - 2 Jun 2006
Introgen's ADVEXIN p53 Therapy Demonstrates Clinical Benefit in Inherited Cancer
Introgen's ADVEXIN p53 Therapy Demonstrates Clinical Benefit in Inherited Cancer
HSMN NewsFeed - 10 Apr 2006
Novartis completes submissions in US and Europe for Gleevec(R) as treatment for four rare types of cancer
Novartis completes submissions in US and Europe for Gleevec(R) as treatment for four rare types of cancer
HSMN NewsFeed - 15 Mar 2006
PRAECIS PHARMACEUTICALS INCORPORATED Presents Update on its DirectSelect(TM) Technology
PRAECIS PHARMACEUTICALS INCORPORATED Presents Update on its DirectSelect(TM) Technology
HSMN NewsFeed - 5 Jan 2006
Innovive Pharmaceuticals Licenses Potent Dual Bcr-Abl/Lyn Kinase Inhibitor
Innovive Pharmaceuticals Licenses Potent Dual Bcr-Abl/Lyn Kinase Inhibitor
Additional items found! 43

Members Archive contains
43 additional stories matching:
Gleevec
(Password required)
Gleevec
(Password required)